In Australia, NovaTears® Eye Drops Are Available on the Pharmaceutical Benefits Scheme (PBS) from Now On
HEIDELBERG, Germany--(BUSINESS WIRE)--#AFT--Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, is the manufacturer of NovaTears®, a novel topical treatment of dry eye disease (DED) and meibomian gland dysfunction (MGD). AFT Pharmaceuticals Ltd (AFT) commercializes NovaTears® across Australasia. AFT just announced that NovaTears®, its new preservative-free eye lubricant and t